Thames Water odour control framework deal - Hibernia, page-17

First 17 Last

Share
Profile

Follow
Matt48

292 Posts.

3

08/03/17

15:07

Post #: 23188784
Share

Originally posted by Mista_Trix ↑

So yesterday I had a re-read of all of the announcements EVS (PEH) have released since the beginning of last year, took a look through their YouTube videos and Twitter posts ... and I've gotta say I'm feeling much better about the SP (although obviously it would be nicer if it was higher - it'll get there).

- The commentary around not just Thames but other business ventures is incredibly positive, and has been the entire year.
- Their marketing material looks fantastic, by comparison to major players in other markets, but even more so for the kinds of businesses they're up against.
- The sales pipe looks good and growing.
- The relationship with Odornet(via the European expansion video) looks really positive, they clearly have a lot of mutual respect for each other, and trust each others judgement - they wouldn't have gone for such a large distribution venture together if they didn't.
- The management team is slim and agile (which is a positive compared to most other companies on the ASX).
- They're attending a huge number of conferences and dramatically growing exposure.
- Every win they are getting helps grow SAAS revenue (even if for some reason they are not announcing all of them).

It cant stay down here forever, looks like the company value is about even with turnover ... which is just crazy - is the Envirosuite platform really worth nothing on top of the consulting business?? I don't think so.

Call me crazy but I purchased more. This company hasn't even had its first major contract yet (one with many, many sites) and to be perfectly honest if its not Thames then it will be someone else - its time is coming fast.

Expand

you've encouraged me mista-trix....i just hope its well founded encouragement

EVS Price at posting: 5.1¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

CHW

Cleo adds Royal Women's Hospital to its clinical trial for ovarian cancer diagnosis

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

There are more pages in this discussion • 10 more messages in this thread...

First 17 Last

Add EVS (ASX) to my watchlist

(20min delay)
Last 5.2¢		Change 0.000(0.00%)		Mkt cap ! $99.87M

Open	High	Low	Value	Volume
5.2¢	5.2¢	5.2¢	$11.5K	221.1K

Buyers (Bids)

No.	Vol.	Price($)
1	237406	5.1¢

Sellers (Offers)

Price($)	Vol.	No.
5.2¢	14373	1

View Market Depth

No.	Vol.	Price($)
2	31009	0.160
1	74247	0.155
10	742532	0.150
7	544595	0.145
4	319049	0.140

Price($)	Vol.	No.
0.165	126720	2
0.170	625000	3
0.175	120000	1
0.180	68832	2
0.185	140908	2

Last trade - 10.02am 27/11/2024 (20 minute delay)

EVS (ASX) Chart

Thames Water odour control framework deal - Hibernia, page-17

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Cleo adds Royal Women's Hospital to its clinical trial for ovarian cancer diagnosis

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Buyers (Bids)

Sellers (Offers)